Atnaujinkite slapukų nuostatas

Pediatric Thromboembolism and Stroke 3rd Revised edition [Minkštas viršelis]

  • Formatas: Paperback / softback, 228 pages, aukštis x plotis x storis: 157x104x9 mm, weight: 140 g
  • Išleidimo metai: 01-Jan-2006
  • Leidėjas: B.C. Decker Inc
  • ISBN-10: 1550093584
  • ISBN-13: 9781550093582
Kitos knygos pagal šią temą:
  • Formatas: Paperback / softback, 228 pages, aukštis x plotis x storis: 157x104x9 mm, weight: 140 g
  • Išleidimo metai: 01-Jan-2006
  • Leidėjas: B.C. Decker Inc
  • ISBN-10: 1550093584
  • ISBN-13: 9781550093582
Kitos knygos pagal šią temą:
Three pediatricians explore the secondary thromboembolic diseases that children are living long enough to be susceptible to now that many previously primary lethal disorders have become treatable to various degrees. The 33 chapters discuss the currently available therapies and present guidelines for treatment. Originally published as Thromboembolic complications during infancy and childhood, the third edition adds chapters on interpreting coagulation tests and giving immunizations. Annotation ©2007 Book News, Inc., Portland, OR (booknews.com)
Preface v
Introduction vii
Section 1: Useful Information
Developmental Hemostasis
3(28)
Vascular Anatomy
31(7)
Common Cardiac Surgical Procedures
38(5)
Anticoagulant Generic and Trade Names
43(3)
Section 2: Diagnosis Of Thromboembolic Disease In Children
Diagnosis of Noncerebral Venous Thrombosis
46(8)
Diagnosis of Noncerebral Arterial Thrombosis
54(5)
Diagnosis of Cerebral Sinovenous Thrombosis
59(5)
Diagnosis of Arterial Ischemic Stroke
64(6)
Diagnosis of Thrombophilic Conditions
70(7)
Section 3: Antithrombotic Therapy In Children
Heparin Therapy
77(8)
Low-Molecular-Weight Heparin Therapy
85(8)
Subcutaneous Catheters
93(3)
Management of Heparin-Induced Thrombocytopenia
96(8)
Vitamin K Antagonists: Warfarin and Acenocoumarol Therapy
104(12)
Warfarin Education
116(6)
Elective Reversal of Warfarin Therapy
122(4)
Systemic Thrombolytic Therapy
126(9)
Antiplatelet Therapy
135(4)
Surgical Interventions for Thromboembolic Disease
139(2)
Newer Anticoagulant Drugs
141(5)
Section 4: Guidelines For Antithrombotic Therapy In Specific Situations
Management of Blocked Central Venous Lines
146(5)
Treatment of Deep Venous Thrombosis
151(7)
Management of Post-thrombotic Syndrome
158(2)
Anticoagulation Therapy for Specific Cardiac Conditions and Surgery of Childhood
160(4)
Anticoagulation Therapy for Artificial Heart Valve
164(3)
Treatment of Coronary Artery Disease in Children
167(3)
Neonatal Purpura Fulminans
170(3)
Renal Vein/Portal Vein Thrombosis
173(3)
Management of Arterial Thrombosis
176(11)
Section 5: Guidelines For Antithrombotic Therapy In Stroke
Acute Arterial Ischemic Stroke
187(8)
Sinovenous Thrombosis
195(5)
Stroke in Sickle Cell Disease
200(3)
Section 6: Guidelines For Procedural Interventions In Children On Anticoagulant Therapy
Procedural Interventions
203(3)
Appendix Useful Web Sites, References, and Contacts 206(4)
Index 210


Paul Monagle, MBBS, MD, MSc, FRACP, FRCPA, FCCP Professor, Chair, Head Department of Pathology University of Melbourne Director, Haematology Department of Pediatrics Royal Children's Hospital Melbourne, Australia Anthony K.C. Chan, MBBS, FRCPC Career Investigator, Heart and Stroke Foundation of Canada Medical Director, Coagulation Laboratory The Hospital for Sick Children, Toronto, Canada Professor of Pediatrics McMaster University, Hamilton, Canada M Patricia Massicotte, MD, MHSc Peter Olley Chair in Pediatric Thrombosis Professor, Pediatrics University of Alberta Edmonton, Canada Gabrielle deVeber, MD, FRCPC, MHSc Associate Professor, Department of Pediatrics University of Toronto Scientist, Population Health Sciences The Hospital for Sick Children Research Institute Director, Children's Stroke Program, Division of Neurology The Hospital for Sick Children Toronto, Canada